Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Neuraxis, Inc.

NRXSNYSE_AMERICANEQUITYCurrent

Changes in Beneficial Ownership

Filed Aug 17, 2026Accepted Aug 17, 2026, 6:23 PM EDTFiling CIK 1933567Accession 0001493152-26-038815
Share

Structured filing — 4

ownership.xml

Open full document ↗

Filing details

Report period
2026-08-13
Issuer
Neuraxis, INC
Issuer CIK
0001933567
Trading symbol
NRXS

Reporting owner 1

Name
Aharon Gil
Reporting owner CIK
0001811824
Relationship
Director
Address
15 WELLESLEY STREET WEST, SUITE 326, TORONTO, ONTARIO, CANADA, A6, A6, M4Y 0G7

Non-derivative transactions

Non-derivative transactions · 3 reported rows
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnershipNature of ownership
Common Stock2026-07-29A · Form 42,226[F1]A[F1]36,128D
Common Stock2026-08-13A · Form 443,930[F2]A6.28[F2]80,058D
Common Stock2026-07-29A · Form 440,068[F1]A[F1]548,123IBy Rosalind Advisors, Inc., the advisor to the Rosalind Master Fund L.P.[F3]
Table key
A · Form 4
Acquisition by grant, award or otherwise under Rule 16b-3(d)
A
Acquired
D
Direct
I
Indirect

Footnotes

F1
The number of shares of common stock issued as a dividend on the Series B Preferred Stock to Rosalind Master Fund L.P. and the Reporting Person were 40,068 and 2,226, respectively, and was determined by dividing the accrued and unpaid 8.5% cumulative dividends on the respective Series B Preferred Stock (from the investment date, through the applicable record or conversion date) by $2.38.↩ 1↩ 2↩ 3↩ 4
F2
These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.↩ 1↩ 2
F3
Each Reporting Persons disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein.↩ 1

Signature 1

Signed
/s/ Gilad Aharon
Date
2026-08-17

Company context

Current securities

Recent company filings

  1. SCHEDULE 13G/A - filed by BIGGER CAPITAL FUND L P regarding Neuraxis, INCNov 10, 2026
  2. 10-Q filingNov 9, 2026
  3. Other EventsOct 14, 2026
  4. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other EventsAug 19, 2026
  5. 4 filingAug 17, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.